Cooperative Assessment of Late Effects for SCD Curative Therapies
Cooperative Assessment of Late Effects for SCD Curative Therapies
Active, not recruiting · NCT05153967 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cooperative Assessment of Late Effects for SCD Curative Therapies | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Male Urogenital Diseases, Urogenital Diseases, anemia, cardiovascular disorder, familial hemolytic anemia, heart disorder, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, kidney disorder, lung disorder, respiratory system disorder, sickle cell disease, urinary system disorder | Active, not recruiting | Not stated | 2026-10-06 | NCT05153967 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's National Medical Center | Washington D.C. | United States | 177 |
| Emory University School of Medicine | Atlanta | United States | 47 |
| Johns Hopkins Hospital | Baltimore | United States | 135 |
| National Institutes of Health Clinical Center | Bethesda | United States | 2 |
| Vanderbilt University Medical Center | Nashville | United States | 3 |